# genai-lab: A Cutting-Edge Lab Reconstructing Computational Biology with Generative AI

> A systematic open-source project exploring the application of generative AI technologies such as VAE, diffusion models, and Transformer to computational biology, covering key areas like single-cell analysis, gene expression prediction, and drug perturbation response modeling.

- 板块: [Openclaw Geo](https://www.zingnex.cn/en/forum/board/openclaw-geo)
- 发布时间: 2026-06-01T21:11:20.000Z
- 最近活动: 2026-06-01T21:18:09.478Z
- 热度: 145.9
- 关键词: 生成式AI, 计算生物学, VAE, 扩散模型, 单细胞RNA测序, 药物发现, Perturb-seq, 基因表达预测, 基础模型, 生物信息学
- 页面链接: https://www.zingnex.cn/en/forum/thread/genai-lab-ai
- Canonical: https://www.zingnex.cn/forum/thread/genai-lab-ai
- Markdown 来源: floors_fallback

---

## genai-lab: Cutting-Edge Exploration of Reconstructing Computational Biology with Generative AI

genai-lab is a systematic open-source project aimed at applying generative AI technologies such as VAE, diffusion models, and Transformer to core scenarios in computational biology, covering areas like single-cell analysis, gene expression prediction, and drug perturbation response modeling. Positioned as an end-to-end research and application platform, it focuses on key applications like Perturb-seq perturbation prediction to facilitate drug discovery and life science research.

## Project Background and Core Positioning

Generative AI is reshaping life sciences (e.g., AlphaFold solved protein structure prediction). genai-lab is not limited to reproducing a single model; its goal is to build a complete chain covering theoretical derivation, model implementation, and practical biological problems. Its flagship application is Perturb-seq perturbation prediction, which can simulate cell expression changes under drug or gene intervention, significantly reducing experimental costs.

## Technical Architecture: Biological Adaptation of Multiple Generative Models

1. VAE family: CVAE_NB (modeling gene expression count characteristics with negative binomial distribution), CVAE_ZINB (zero-inflation handling for scRNA-seq zero values), conditional design (injecting drug/cell type information);
2. Diffusion models: DDPM, Latent Diffusion (latent space diffusion reduces computational cost), DiT (Transformer replaces U-Net), Score/Flow Matching;
3. Foundation model adaptation: LoRA fine-tuning, Adapter insertion, hierarchical freezing strategy for adapting pre-trained models.

## Industry Benchmarking and Documentation System

**Industry Benchmarking**: Benchmarked against platforms like Synthesize Bio (gene expression synthesis), Arc Institute (DNA sequence modeling), and Geneformer (single-cell analysis), providing a migration path from academia to industry;
**Documentation System**: Includes mathematical derivations (VAE ELBO, diffusion process), architecture design (DiT/JEPA adaptation), application guides (Perturb-seq tutorials), and dataset descriptions, serving both as a codebase and a learning resource.

## Current Status and Future Roadmap

**Completed**: Theoretical documentation system, core model implementation, standardized data preprocessing;
**In Progress**: Improving Perturb-seq application, public method benchmark comparison;
**Planned**: Integrating causal inference (collaboration with causal-bio-lab), hybrid predictive generative models, biology-aware synthetic data pipelines.

## Practical Significance and Summary

**Practical Significance**: Provides researchers with a systematic tech stack, production-grade code, cutting-edge method tracking, and open collaboration; accelerates PoC transformation for drug discovery in industry;
**Summary**: genai-lab embodies the "domain knowledge-driven" AI for Science paradigm, deeply adapts to biological data characteristics, and is a noteworthy open-source project in the intersection of AI and computational biology.